Xevant – a leader and creator of automated data analytics for organizations managing pharmacy benefits – announced the completion of a new investment round with HCAP Partners, a California-based private equity firm and nationally recognized impact investor.
As the most comprehensive and independent pharmacy analytics platform available, Xevant provides customized pharmacy benefit managers, payers, hospitals, and consultants customized solutions that can streamline decades-old analytic processes, resulting in lower drug costs and optimized performance and efficiencies.
With this latest funding round, the company will further expand its unique position to positively impact pharmacy benefit stakeholders and advance its long-held mission of revolutionizing healthcare services with its real-time automation platform.
KEY QUOTES:
“Xevant’s innovative solutions and talented team of experts are changing the way that access, quality, and cost issues are approached by healthcare stakeholders. We are excited to enter this partnership as the company embarks on the next phase of its growth journey and continues to bring world class solutions to market.”
– Frank Mora, HCAP Senior Partner
“The successful completion of our latest investment round is a testament to the strength and potential of Xevant. This new infusion of capital will enable us to accelerate our growth plans, expand our team, and continue delivering cutting-edge solutions that drive value and improve outcomes in healthcare. We are grateful for the support and confidence from HCAP Partners and look forward to the exciting opportunities ahead.”
– Brandon Newman, Xevant CEO
